Agency Information Collection Activities; Submission for OMB Review; Public Comment Request; Information Collection Request for the State Grants for Assistive Technology Program Annual Progress Report; OMB #0985-0042
| Published date | 05 January 2021 |
| Citation | 86 FR 310 |
| Record Number | 2020-29150 |
| Section | Notices |
| Court | Community Living Administration |
310
Federal Register / Vol. 86, No. 2 / Tuesday, January 5, 2021 / Notices
A
NNUAL
B
URDEN FOR
R
ECORD
K
EEPERS
—Continued
Information collection title
Annual
number of
record
keepers
Annual
number of
responses
per record
keeper
Average
burden
hours per
response
Annual
total burden
hours
Sponsor Verification Application (Form SVP–3/3s)—Cases requiring a Fi-
nancial Care Plan ......................................................................................... 216 87 1.00
Sponsor Verification Application (Form SVP–3/3s)—Applicants choosing to
submit to an ORR-paid DNA test ................................................................. 216 78 1.00
Sponsor Care Agreement (SVP–4/4s) All UAC check-in ................................ 216 265 0.75 42,930
Sponsor Care Agreement (SVP–4/4s) All UAC check-in ................................ 11 5,200 3.00 171,600
Fingerprinting Instructions (SVP–7/7s) ............................................................ 216 177 1.00 38,232
Letter of Designation for Care of a Minor (Form SVP–9/9s) .......................... 216 79 0.50 8,532
Estimated Annual Burden Hours Total ..................................................... ........................ ........................ ........................ 714,246
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: 6 U.S.C. 279; 8 U.S.C. 1232;
Flores v. Reno Settlement Agreement, No.
CV85–4544–RJK (C.D. Cal. 1996).
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–29117 Filed 1–4–21; 8:45 am]
BILLING CODE 4184–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Agency Information Collection
Activities; Submission for OMB
Review; Public Comment Request;
Information Collection Request for the
State Grants for Assistive Technology
Program Annual Progress Report;
OMB #0985–0042
AGENCY
: Administration for Community
Living, HHS.
ACTION
: Notice.
SUMMARY
: The Administration for
Community Living is announcing that
the proposed collection of information
listed above has been submitted to the
Office of Management and Budget
(OMB) for review and clearance as
required under section 506(c)(2)(A) of
the Paperwork Reduction Act of 1995.
This 30-day notice collects comments
on the information collection
requirements related to the
reinstatement with change for the
information collection requirements
related to State Grants for Assistive
Technology Program Annual Progress
Report [OMB #0985–0042].
DATES
: Submit written comments on the
collection of information by February 4,
2021.
ADDRESSES
: Submit written comments
and recommendations for the proposed
information collection within 30 days of
publication of this notice to
www.reginfo.gov/public/do/PRAMain.
Find the information collection by
selecting ‘‘Currently under 30-day
Review—Open for Public Comments’’ or
by using the search function. By mail to
the Office of Information and Regulatory
Affairs, OMB, New Executive Office
Bldg., 725 17th St. NW, Rm. 10235,
Washington, DC 20503, Attn: OMB Desk
Officer for ACL.
FOR FURTHER INFORMATION CONTACT
:
Robert Groenendaal, Assistive
Technology Program Manager, Center
for Innovation and Partnership in the
Office of Interagency Innovation
Administration for Community Living;
Email: Robert.Groenendaal@acl.hhs.gov;
Phone: 202–795–7356.
SUPPLEMENTARY INFORMATION
: In
compliance with 44 U.S.C. 3507, ACL
has submitted the following proposed
collection of information to OMB for
review and clearance.
The Administration for Community
Living (ACL) is requesting approval for
a reinstatement with change for the
information collection associated with
the State Grants for Assistive
Technology Program Annual Progress
Report (AT APR) 0985–0042.
The information collected through
this data collection instrument is
necessary for ACL and states to comply
with Sections 4 and 7 of the Assistive
Technology Act of 1998, as amended
(AT Act). ACL is requesting a
reinstatement with change of a
previously approved information
collection under OMB No. 0985–0042.
Section 4 of the AT Act authorizes
grants to public agencies in the 50 states
and the District of Columbia, Puerto
Rico, the Virgin Islands, Guam,
American Samoa, and the
Commonwealth of the Northern
Marianas (states and outlying areas).
With these funds, the 56 states and
outlying areas operate ‘‘Statewide AT
Programs’’ that conduct activities to
increase access to and acquisition of
assistive technology (AT) for
individuals with disabilities and older
Americans. Divided into two
comprehensive activity categories:
‘‘State-level Activities’’ and ‘‘State
Leadership Activities.’’ According to
Section 4 of the AT Act, as a condition
of receiving a grant to support their
Statewide AT Programs, the 56 states
and outlying areas must provide to ACL:
(1) Applications and (2) annual progress
reports on their activities.
Applications: The application
required of states and outlying areas is
a three-year State Plan for Assistive
Technology (State Plan for AT or State
Plan) (OMB No. 0985–0048). The
content of the State Plan for AT is based
on the requirements in Section 4(d) of
the AT Act. As a part of this State Plan,
Section 4(d)(3) of the AT Act requires
that states and outlying areas set
measurable goals for addressing the
assistive technology needs of
individuals with disabilities in
education, employment, community
living and information technology/
telecommunications.
Every state and outlying area is
required to include a minimum of seven
prescribed measurable goals in its State
Plan. These seven goals apply to all
VerDate Sep<11>2014 17:09 Jan 04, 2021 Jkt 253001 PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 E:\FR\FM\05JAN1.SGM 05JAN1
jbell on DSKJLSW7X2PROD with NOTICES
311
Federal Register / Vol. 86, No. 2 / Tuesday, January 5, 2021 / Notices
states and outlying areas in order to
aggregate information on performance of
the program at the national level.
National aggregation of data related to
these goals is necessary for the
Government Performance and Results
Modernization Act of 2010 (GPRAMA)
(Pub. L. 111–352), as well as an Annual
Report to Congress (see ‘‘Section 7
Requirements Necessitating Collection’’
below).
Therefore, this data collection
instrument provides a way for all 56
grantees—50 U.S. states, DC, Puerto
Rico, the U.S. Virgin Islands, Guam,
American Samoa, and the
Commonwealth of the Northern Mariana
Islands to collect and report data on
their performance in a consistent
manner, including a uniform survey to
be given to consumers. This uniform
survey is included as part of the data
collection package.
Annual Reports: In addition to
submitting a State Plan every three
years, states and outlying areas are
required to submit annual progress
reports on their activities. The data
required in that progress report is
specified in Section 4(f) of the AT Act.
Section 7(d) of the AT Act requires
that ACL submit to Congress an annual
report on the activities conducted under
the Act and an analysis of the progress
of the states and outlying areas in
meeting their measurable goals.
This report must include a
compilation and summary of the data
collected under Section 4(f). In order to
make this possible, states and outlying
areas must provide their data uniformly.
This data collection instrument was
developed to ensure that all 56 states
and outlying areas report data in a
consistent manner in alignment with the
requirements of Section 4(f).
As stated above, ACL will use the
information collected via this
instrument to:
(1) Complete the annual report to
Congress required by the AT Act;
(2) Comply with reporting
requirements under the Government
Performance and Results Modernization
Act of 2010 (GPRAMA) (Pub. L. 111–
352); and
(3) Assess the progress of states and
outlying areas regarding measurable
goals in their State Plans for AT.
Data collected from the grantees will
provide a national description of
activities funded under the AT Act to
increase the access to and acquisition of
AT devices and services through
statewide AT programs for individuals
with disabilities. Data collected from
grantees will also provide information
for usage by Congress, the Department,
and the public. In addition, ACL will
use this data to inform program
management, monitoring, and technical
assistance efforts. While States will be
able to use the data for internal
management and program improvement.
Comments in Response to the 60-Day
Federal Register Notice
A notice published in the Federal
Register on September 28, 2020 in 85
FR 60803. There were 32 public
comments received during the 60-day
FRN comment period.
Proposed change in State Financing
Activities: Financial Loan—partnership
loans reported with no guarantee or
interest buy-down have narrative
description added to document subsidy/
investment.
Comment Summary: Two State AT
Act Program grantees commented in
support. One organization representing
the State AT Act Programs requested
clarification.
ACL Response: Sentence identified as
confusing has been deleted in the AT
APR—IC document.
Proposed change in Reuse:
Exchange—option for automatic
exclusion of exchange recipients from
performance measure data collection
eliminated.
Comment Summary: Two AT grantees
commented in support. One AT
organization requested clarification.
ACL Response: Clarification text has
been added into the AT APR—IC
document.
Proposed change in Device Loan—
separate type of borrower and type of
device data reporting tables by purposed
of loan.
Comment Summary: Three AT
grantees commented in support. One
requested clarification of timeline for
implementation.
ACL Response: No changes made.
ACL will clarify the timeline for
implementation to begin with federal
fiscal year 2022, with first data
collection October 1, 2021 to provide
time for data system revision.
Proposed change in Device
Demonstration—separate decision-
making participant from other
participants reported in participant type
table.
Comment Summary: Three AT
grantees commented in support. One
grantee and one organization
commented in opposition with one
saying this is duplicative data reporting
and one saying it is understood that an
individual with a disability is the
decision-maker unless unable to be and
then it is the caregiver/provider role.
One grantee requested clarification of
the timeline for implementation.
ACL Response: The proposed change
is designed to support data fidelity by
ensuring the decision-maker is
identified by type within what can be a
larger number of participants reported
for each demonstration event. Currently
all participants are reported by type. As
a result, this change does not duplicate
or increase data reporting burden. It
only separates the decision-maker
participant type reported from the type
or types reported for all other
participants. No change is made. ACL
will clarify the timeline for
implementation to begin with federal
fiscal year 2022, with first data
collection October 1, 2021 to provide
time for data system revision.
Updated Outcome Measures—Overall
acquisition and access performance
measure tables and consumer
satisfaction tables updated to align with
outcome/output data and targets used
by ACL for program evaluation and
budget justification since FY18.
Comment Summary: One AT
organization requested clarification.
ACL Response: Clarification has been
added to the AT APR—IC document.
Proposed new data elements in Public
Awareness and Information &
Assistance—New question added for
description of partnerships as part of
public awareness, new data table added
to report how individuals learned about
the AT Program, new information
request in Notes for description of
partnerships that increase referrals.
Comment Summary: Five AT grantees
and one AT organization commented in
opposition to these changes and the new
data element. All commenters expressed
concern about lack of clarity and
significant new data burden (both for
AT Programs and consumers) associated
with the proposed new data collection
requirements.
Commenters suggested these new data
elements be removed and requested
ACL work with AT Act grantees to
determine the most efficient and
effective way to report referral source
data in a future information collection.
ACL Response: ACL is appreciative of
the participation of AT stakeholders in
the Federal Register Notice comment
process and values the submission of
comments on the proposed updates to
the Public Awareness and Information
and Assistance sections of the AT APR
data collection instrument. Once
approved, ACL intends to address and
work through these changes with AT
stakeholders to identify the most
efficient and effective way to collect
referral source data in the Information
Collection.
State Improvement Outcomes—new
optional section added to collect data on
VerDate Sep<11>2014 17:09 Jan 04, 2021 Jkt 253001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\05JAN1.SGM 05JAN1
jbell on DSKJLSW7X2PROD with NOTICES
312
Federal Register / Vol. 86, No. 2 / Tuesday, January 5, 2021 / Notices
coordination and collaboration with two
new required narratives and associated
drop-down menu data.
Comment Summary: Two AT grantees
commented in support.
ACL Response: No changes made.
Leveraged Funding—eliminated
Section B and folded data into Section
A to simplify.
Comment Summary: Two AT grantees
commented in support.
ACL Response: No changes made.
Instruction Manual—deleted
redundant text and updated AT
Taxonomy.
Comment Summary: Two AT grantees
commented in support.
ACL Response: No changes made.
Estimated Program Burden
ACL estimates the burden associated
with this collection of information as
follows:
(A) A web-based system that collects
data from states.
(B) A performance measurement
survey that states collect from
individuals
(C) A customer satisfaction survey
that states collect from individuals.
(A) Fifty-six grantees report to ACL
using the web-based data collection
system. A workgroup of grantees
estimated that the average amount of
time required to complete all responses
to the data collection instrument is 80
hours annually. The estimated response
burden includes time to review the
instructions, gather existing data, and
complete and review the data entries.
These estimates are based on the
experience of staff who implement these
programs at the state level. In addition,
we project that clean-up and
clarification of data elements will
require no change in data burden
estimates.
(B) The fifty-six grantees ask
consumers to complete surveys that
provide information on their
performance related to the state’s
measurable goals. Historical data from
states indicates that the average state
will ask for this information from 3,242
consumers at 1 minute per consumer to
complete the question survey, for a total
of 54 hours annually.
(C) The fifty-six grantees also ask
consumers to complete customer
satisfaction surveys. Historical data
from states indicated that the average
state asks for this information from
3,242 consumers at 1 minute per
consumer, for a total of 54 hours
annually.
Number of
responses Hours per
response
Annual
burden per
grantee
Total annual
burden hours
Work-Based System ........................................................................................ 56 1.428 80 4,480
Performance Measurement ............................................................................. 3,242 0.01666 54 3.024
Customer Satisfaction ...................................................................................... 3,242 0.01666 54 3,024
Subtotal ..................................................................................................... ........................ ........................ 188 10,528
Program Support ............................................................................................. 56 4 208 11,648
Record Keeping Burden .................................................................................. 56 0.14286 8 448
Subtotal ..................................................................................................... ........................ ........................ 216 12,096
Total ................................................................................................... ........................ ........................ 404 22,624
Dated: December 29, 2020.
Lance Robertson,
Administrator and Assistant Secretary for
Aging.
[FR Doc. 2020–29150 Filed 1–4–21; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–D–2105]
Mouse Embryo Assay for Assisted
Reproduction Technology Devices;
Guidance for Industry and Food and
Drug Administration Staff; Availability
AGENCY
: Food and Drug Administration,
HHS.
ACTION
: Notice of availability.
SUMMARY
: The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a final
guidance entitled ‘‘Mouse Embryo
Assay for Assisted Reproduction
Technology Devices.’’ This guidance
document provides recommendations
on conducting the mouse embryo assay
to support premarket submissions and
lot release of assisted reproduction
technology devices.
DATES
: The announcement of the
guidance is published in the Federal
Register on January 5, 2021.
ADDRESSES
: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
Electronic Submissions
Submit electronic comments in the
following way:
•Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
•If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
•Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
•For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
VerDate Sep<11>2014 17:09 Jan 04, 2021 Jkt 253001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\05JAN1.SGM 05JAN1
jbell on DSKJLSW7X2PROD with NOTICES
